INTRODUCTION
C hronic venous insufficiency (HVI) represents a number of complex pathologycal conditions which lead to progressive venous stasis because of the constant increase of venous pressure, and consequently to inflammatory and trophic lesions of skin, subcutaneous tissue, and subfascial structures of the distal parts of lower limbs. Lipodermatosclerosis and venous ulcer are the terminal stages of HVI. It is supposed that approximately one half of entire European and North American adult population suffers from some degree of HVI.
The classification of HVI is based on clinical manifestations and other characteristics of the disorder. The earlier classification used to describe four stages of HVI: asymptomatic, mild, moderate, and severe venous stasis. However, CEAP classification has been generaly adopted: Cclinical manifestations, E -etiology, A -anatomical distribution, P -patophysiology (Table 1) .
Venous ulcerations appear in approximately 1-2% of Western countries population. The prevalence of this disorder is between 2 -6.4/1000 2 and is connected with the patient's age. The average age of the patient is lower for men (67, range 22-96), than for women (74, range 21 -100). The disorder is more frequent among women than among men (ratio 3:2) 2 . Socioeconomic significance of the disorder is enormous. In the USA approximately 2.000.000 working days are lost annually due to venous ulcers . Moreover, the indirect costs (absence from work, permanent disability and early retirement) additionally increase the cost of the treatment of such patients. Thus, it is important to start the treatment in the early stages of CEAP, instead in the terminal stage of HVI.
HVI is a result of the incompetence of the superficial, deep, and perforating veins. 10-25% of all patients with HVI and venous ulcers are diagnosed as having isolated incompetence of the superficial veins, and 15% of patients are diagnosed as having isolated incompetence of perforating veins 5 . The incompetence of the deep veins leads to severe local metabolic disorders 6 and ulcerations refractory to treatment 5, 6 . Venous reflux is rarely isolated to a single segment of a vein, but rather results in a progressi-ve stasis and disorder of complete venodynamics. Therefore, pathological reflux of blood through the incompetent perforating veins significantly increases microcirculation pressure as a rule, which was observed at all HVI patients 6 . This leads to subcutaneous oedema and changes in the skin (lipodermatosclerosis), usually accompanied with eczematous dermatitis. The oedema progressively interferes with the normal transportation of the nutritious substance to the tissue 3 because of the high interstitial pressure, which results in a capillary collapse with increased blood flow in lipodermosclerotic and ulcerated skin 2, 3 . There are several theories dealing with venous ulcerations: stasis, and hypoxia, pathological arterial-venous fistulas, pericapillary blockade of exchange, and Le entrapment 2, 5 . The most important symptoms and signs of HVI are swelling, pain, feeling of heaviness and tightness in the legs. Persistent and progressive nature of these symptoms leads to physical, social, and psychological suffering of patients, significantly affecting their quality of life. 2, 3, 5 The diagnosis of HVI is based on the personal history, clinical examination, color duplex scan, and rarely other diagnostic procedures (phlebography, CT, MRI) 3, 5 .Treatment for HVI should be based on etiology, pathogenesis, and CEAP classification of venous stasis. There are several agents used for treatment: local treatment, graded elastic compressive bandage, drugs, sclerotherapy and surgery.
Treatment for HVI should be started as soon as possible, i.e. before the ulcerations develop. External compressive bandage had been used for venous disorders ever since Hippocrates. It was shown that this treatment improves flow through the magistral veins as well as micro vascular dynamics by reducing oedema and improving skin nutrition 2. Graded compression (30 -40 mmHg on medial malleolus) is more effective than a uniform bandage 2 . Compression by elastic stockings or bandages reduces lipodermatosclerosis and significantly improves healing of venous ulcerations 2, 5 , thus it is indicated either independently or as adjuvant therapy for HVI and venous ulcerations. The administration of medicaments to HVI patients should be rational and based on the established microcirculation disorders. Hydroxy-rutosides, flavonoids from plant glycosides, reduce the rate of capillary filtration which reduces oedema and results in a clinical improvement of HVI 2 . Semisynthetic diosmin (7-rhamnoglucoside 5,7,5' -trihydroxy 4-metoxy flavone) acts selectively venotonic, vasculoprotective and anti-inflammatory 7 .
THE AIM
The aim of the study is to examine the following HVI parameters, before and after the administration of semi synthetic diosmin:
1. clinical symptoms and signs of HVI (pain, swelling, heaviness, and tightness), 2.quality of life (physical, social, psychological), 3. stage of CEAP classification, 4. local metabolic status (lactates, gas analysis). 
MATERIALS AND METHODES
The prospective study ( ) were not included in the study. Each patient's clinical signs (pain, oedma, feeling of heaviness and tightness in the lower limbs, measured on a scale from 0 to 3, 0 meaning no symptoms were found), quality of life -physical, social, and psychological parameters (a scale from 1 to 5, 5 representing the most favourable degree), and CEAP classification of HVI were assessed prior to and 30 days after the treatment with semisynthetic diosmin. 15 patients with unilateral HVI took additional tests: lactates (mmol/l) and gass analysis: acidity (pH), partial oxygene pressure pO2 (mmol/l), oxygene saturation -SO2 (%), partial pressure of CO2 -pCO2 (mmol/l), and total CO2 -T CO2 (mmol/l) in the venous blood samples taken from the affected region (B sample), and an approximate level of the collateral, helaty leg (Z sample) while resting (0 sample), and after 30 minutes of passive standing (S sample). All samples were taken directly before the study started (day 0) and after one -month treatment with the tested medication (day 30).
The results were processed by means of descriptive statistics (mean value -X, and standard deviation -SD), while the statistic significance of nonparametric features was measures by Wilcoxon signed-rank test (Z).
THE RESULTS
HVI appeared to be somewhat more frequent among women (48) than among men (32), but the difference was not significant. The youngest patient was 36, and the oldest 84 years old (X+ SD = 52.3+10.5). HVI was diagnosed on the left leg (26), right leg (36) or bilaterally (18) . Patients were mostly (46; 57.5%) working under static load. Women had from 0 to 3 deliveries (X+ SD = 1.5 +0.7), and from 0 to 10 (X+ SD = 3.5+2.6) abortions. Positive family history was found at 51 (63.8%) patients. The patients had a personal history of the disorder from 3 to 38 years (X+ SD = 12.5+8.6). Symptoms and signs of venous stasis were more prominent before than after the treatment, and the difference was significant ( Table 2) .
The administration of the medicament treatment resulted in a significant improvement of the quality of life parameters (Table 3) The treatment with Phlebodia 600 ® during a month resulted in an improvement of CEAP stage for 32 patients, with regression of the symptoms and improvement of quality of life. Br. 4 Medicamentous treatment of chronic venous insufficiency 55 using semisynthetic diosmin with an unchanged CEAP stage, the quality of life was assesed as improved (18) , worsened (3), unchanged (27), (Graph 2).
One-month treatment with diosmin resulted in a significant improvement of redistribution of patients by CEAP classification (Table 4 , Graph 3).
Although the level of lactates measured prior to treatment, and under static load, was higher comparing to the levels after the treatment, the difference was not significant (Table 5) . DISCUSSION Chronic venous insufficiency affects women more frequently, but the difference is not as significant as it used to be described, becasue increasing number of men is getting affected by HVI. In our population women:men ratio was 3:2 5. The disorder affects adult population, no matter the age.
However, its incidence is the largest in the sixth and seventh decade 10 . Our population included somewhat younger patients (î SD = 52.3 10.5). The professions requiring long -lasting passive static load may be considered a significant risk factor for HVI. This finding is consistent with all relevant studies 5, 11 . Similarly, HVI is more frequent among patients with a positive family history 2, 5, 11 . The duration of the symptoms of the patients included in our study varied (3 to 38 years), which is also consistent with other studies 9 .
The most frequent and the most prominent clinical signs of venous stasis are feeling of heaviness and tightness, followed by pain and swelling 2, 5, 11 . Being persistent and marked, these symptoms significantly interfere with physical, social, and psychological quality of life 10 . With the exception of feeling of tightness, wich appears to be less frequent, all other symptoms were almost identical for all our patients and consistent with similar prospective studies 2, 9 .
The frequency of the symptoms and the signs of HVI were significantly improved after a month of treatment with semi synthetic diosmin (Table 2) , as in similar studies. Thus, the improvement of all parameters of quality of life achieved with this agent is highly significant (Table  3) , as found also by other researchers 2, 9 . A month of treatment with semi synthetic diosmin resulted in an improvement of CEAP stage of HVI for the half of the treated patients, and for the most of the patients without an improvement of CEAP a relevant clinical improvement was recorded (Table 4 , Graph 1).
Results of distribution by CEAP stages and patients' quality of life with HVI were similar (Table 3, Graph 2). Pinjala et al. 9 reported that purified flavonoid fraction administered for 6 months to 308 patients with HVI resulted in regression of CEAP stage (53.9%), did not change CEAP stage but decreased the symptoms (29.5%), did not change CEAP but resulted in a deterioration of the symptoms (8.1%), and finally resulted in a progression of CEAP stage (8.5%). The results of this study show that semi synthetic diosmin significantly improves CEAP classification of HVI for patients treated for a month (Table 4 , Graph 3), which is more beneficial compared with the research of purified flavonoid fraction 9 . It was also demonstrated that semi synthetic diosmin decreased the capillary filtration rate for patients with HVI, with consequent reduction of oedema and clinical improvement 12 . Also, it was shown that semi synthetic diosmin (7-rhamnoglucoside 5,7,5' -trihydroxy 4-metoxy flavone) had venotonic, vasculoprotective and anti-inflammatory properties 13, 4 , as well as physically or chemically induced effect on capillary resistance 13, 15. Anti -oedematouse effect is close to anti-inflammatory effect due to inhibition of lipoxygenase, leukocyte migration, and anti-complementary effect 16, 17 . The values of lactate and gas analysis before and after the treatment with semi synthetic diosmin were not significantly changed in the samples of venous blood, even after the static load (Table 5) . The values of gas analysis and anaerobic metabolites in HVI depended on the stage, etiology, localization (deep, perforating, superficial veins) and pathological finding of obstruction or insufficiency 8 . Thus, for patients with C5-6 EpsAspPr stage of HVI the levels of partial pressure and oxygen saturation were decreased, while the levels of carbon dioxide and bicarbonates were increased, and the values of lactate and pyruvate were not significantly changed. For patients with C5-6 EpsAspPr the signs of hyperoxemia were found, and a local increase of lactate and pyruvate levels occurred at the static load 8, 18 .
The results of this study were made on a heterogeneous group of CEAP classification (average value of C stage before administration of semi synthetic diosmin was 3.40 (Table 4 , Graph 3). This explains the fact that it was impossible to demonstrate pathological value of metabolic parameters in such conditions before the administration of the tested drug. Normalization of metabolic parameters after the administration of semi synthetic diosmin could hypothetically be expected only in studies which would include a larger number of patients with venous ulcerations due to various etiologies. Br. 4 Medicamentous treatment of chronic venous insufficiency 57 using semisynthetic diosmin
CONCLUSION
The administration of semisynthetic diosmin for 30 days to patients with chronic venous insufficiency resulted in a significant reduction of swelling, pain, and feeling of heaviness and tightness in legs, accompanied with a significant improvement in physical, social, and psychological quality of life, as well as with highly significant improvement of CEAP classification of chronic venous stasis.
SUMMARY MEDIKAMENTOZNO LE^ENJE HRONI^NE VENSKE INSUFICIJENCIJE PRIMENOM SEMISINTETSKOG DIOSMINA -PROSPEKTIVNA STUDIJA
Uvod: Hroni~na venska insuficijencija (HVI) se manifestuje progresivnim znacima venskog zastoja. Le~enje ovog oboljenja se posti'e razli~itim agensima: kompresivna banda'a, medikamenti, sklerozacija, hirurgija itd.
Cilj rada je prospektivno ispitivanje efekata semisintetskog diosmina (klini~ki znaci, kvalitet 'ivota, lokalni biohemijski parametri) kod bolesnika sa HVI gde nije primenjeno drugo le~enje.
Metod rada Prospektivnom studijom je analizirano 80 bolesnika sa HVI kojima su ispitani faktori rizika i anamnesti~ke osobine. Dijagnoza HVI je utvrdjena na klini~ke slike i kolor dupleks skena. Pre i 30 dana nakon primene Phlebodia 600 R , kod svih bolesnika su odredjivani klini~ki znaci (bol, edem, ose}aj te'ine i raspinjanja), kvalitet 'ivota (fizikalni, socijalni, psiholo{ki) i CEAP stadijum. Kod 15 bolesnika sa unilateralnim variksima odredjivane su i lokalne vrednosti laktata i gasnih analiza u uslovima pre i nakon stati~kog optere}enja, a kontrolni venski uzorci su uzeti iz zdrave noge. Dobijeni podaci su obradjeni metodama deskriptivne statistike, zna~ajnost neparametarskih obele'ja je merena testom Wilcoxonove sume rangova.
Rezultati HVI se ne{to ~e{}e javlja kod 'ena nego kod mu{karaca, i to na levoj nozi a prose~no u uzrastu 52,3+ 10,5 godina. Profesije sa stati~kim optere}enjem i pozitivna porodi~na anamneza se ~esto nalaze kod bolesnika sa HVI. Bolesnici su zapo~injali medikamentozno le~enje prose~no 12,5 +8,6 godina od pojave simptoma oboljenja. Zna~ajno klini~ko pobolj{anje je zabele'eno kod 65/80 ispitanika. Numeri~ke vrednosti pojedinih klini~kih znakova zna~ajno su ni'e nakon primene u odnosu na vrednosti pre primene semisintetskog diosmina: otok (0,94:1,50), bol (1,10:1,84), ose}aj te'ine (1,20:1,96) i raspinjanja (1,14:1,78). Fizi~ki, socijalni i psiholo{ki parametri kvaliteta 'ivota su zna~ajno pobolj{ani nakon primene ispitivanog medikamenta (p<0,0001), a to je bilo pra}eno i visoko zna~ajnim (p<0,0001) popravljanjem CEAP stadijuma HVI (3,00:3,40). Nisu nadjene zna~ajne promene u ispitivanim lokalnim biohemijskim paramaterima.
Zaklju~ak Primena semisinteskog diosmina tokom 30 dana dovodi do zna~ajnog pobolj{anja klini~kih znakova, kvaliteta 'ivljenja i CEAP stadijuma HVI.
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